Please assess the completion status of the following clinical trial:

Trial Title: Health Status and Quality of Life in the Elderly

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females 65-85 years old~* ECOG Performance score 0 to 1~* Body mass index 22-30 kg/m2~* Body weight \>60 kg~* Habit to consume standard breakfast like toast, bread, butter/margarine, eggs, bacon, cereals with milk~* Comply with protocol and likely to be compliant with prescribed product~Exclusion Criteria:~* Renal insufficiency or failure at screening~* Current or previous positive documented history of any chronic inflammatory state including chronic infection, arthritis, or collagen vascular disorder.~* Comorbid medical conditions~* Use of prescription medication for chronic conditions~* Use of hormone replacement therapy (with the exception of levothyroxine)~* Uncontrolled hypertension~* Use of hemostatic agents~* Hemorrhagic disorder and/or coagulation disorder~* Clinically important bleeding within 90 days prior to screening visit~* Fat malabsorption syndromes~* Constipation and/or abdominal pain/discomfort that require dietary supplements or medical therapy~* History of smoking within 1 year prior to visit 1.

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- Placebo capsules (Type: PLACEBO_COMPARATOR): Placebo capsules
- AMP-886 (alpha-tocotrienol) in capsules (Type: EXPERIMENTAL): AMP-886 (alpha-tocotrienol) in capsules

Based on this trial design, predict the completion outcome and termination type (if applicable).